Shuyi Ji

机构：Fudan University · ORCID：0009-0002-5348-1234

发表论文 71 篇 · 总被引 2110 次 · h-index 14

代表论文

• Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy (2024 · Cancer Cell · 被引 70)
• Deciphering the role of the MALT1–RC3H1 axis in regulating GPX4 protein stability (2024 · Proceedings of the National Academy of Sciences · 被引 14)
• DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma (2025 · Developmental Cell · 被引 13)
• Whey Protein Supplementation Combined with Exercise on Muscle Protein Synthesis and the AKT/mTOR Pathway in Healthy Adults: A Systematic Review and Meta-Analysis (2025 · Nutrients · 被引 7)
• CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma (2025 · Proceedings of the National Academy of Sciences · 被引 1)
• XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma (2026 · Cell chemical biology)